Literature DB >> 1470477

The destruction of virulent Entamoeba histolytica by activated human eosinophils.

M López-Osuna1, J Arellano, R R Kretschmer.   

Abstract

Unlike normal (i.e., non-activated) human eosinophils that are unable to destroy virulent Entamoeba histolytica even in the presence of antibodies and complement, activated eosinophils effectively destroy the parasite in vitro without the help of opsonins, yet increase this capacity with their assistance. Many activated eosinophils succumb in the process as well, probably victims of toxic products released by dying amoebae. Human activated eosinophils thus behave more like activated macrophages than like neutrophil polymorphonuclear leucocytes that are notoriously incompetent in dealing with virulent amoebae. As a regular constituent of early inflammatory reactions, and notwithstanding the absence of blood and tissue eosinophilia in invasive amoebiasis, the activated eosinophil may play a role in the defence against E. histolytica.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1470477     DOI: 10.1111/j.1365-3024.1992.tb00030.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  3 in total

Review 1.  Ups and downs of mucosal cellular immunity against protozoan parasites.

Authors:  L H Kasper; D Buzoni-Gatel
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Eosinophils, HLA and amebic disease.

Authors:  R Kretschmer; M López-Osuna
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

Review 3.  The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.

Authors:  Isabel Wong-Baeza; Marcela Alcántara-Hernández; Ismael Mancilla-Herrera; Itzmel Ramírez-Saldívar; Lourdes Arriaga-Pizano; Eduardo Ferat-Osorio; Constantino López-Macías; Armando Isibasi
Journal:  J Biomed Biotechnol       Date:  2010-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.